By Mark John (Reuters) – Failure to tackle climate change and environmental degradation dominate the ranking of top risks facing the planet in the next decade, a World Economic Forum (WEF) surve[...]
Read more
Health
Exclusive-Drugmakers to raise prices on at least 350 drugs in U.S. in January
By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) – Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the[...]
Read more
Analysis-Chinese airlines primed to take advantage of border opening
By Jamie Freed and Sophie Yu SYDNEY/BEIJING (Reuters) – Chinese airlines will be the early winners of the country’s international reopening, analysts say, having kept most widebody planes[...]
Read more
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug
By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen’s Alzhei[...]
Read more
Novartis to pay $245 million to end antitrust cases over Exforge drug generics
By Jonathan Stempel NEW YORK (Reuters) -Novartis AG said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United Stat[...]
Read more
Hershey sued over chocolate containing heavy metals
By Jonathan Stempel NEW YORK (Reuters) – Hershey Co has been sued by a consumer who accused the company of selling dark chocolate that contains harmful levels of lead and cadmium. In a proposed[...]
Read more
Gilead buys out rights to cancer therapy from Jounce for $67 million
(Reuters) – Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for $67 million, the drugmaker said on Tuesday. The amended li[...]
Read more
Analysis-China’s services sector eyes recovery after reopening, but challenges loom
By Joe Cash and Engen Tham BEIJING/SHANGHAI (Reuters) – Jordan Li, a restaurant owner in the southwestern Chinese city of Chengdu, hopes desperately that next month’s Lunar New Year holida[...]
Read more